Glanzmann Thrombasthenia clinical trials at UCSF
1 in progress, 0 open to eligible people
Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders
Sorry, not currently recruiting here
The purpose of the trial is to evaluate the PK, bioavailability, PD, efficacy and safety of MarzAA for on demand treatment and control of bleeding episodes in adult subjects with inherited bleeding disorders.
San Francisco, California and other locations